- Home
- QD vs HQL Comparison
QD vs HQL Comparison
Compare QD & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QD
- HQL
- Stock Information
- Founded
- QD 2014
- HQL 1992
- Country
- QD China
- HQL United States
- Employees
- QD N/A
- HQL N/A
- Industry
- QD Finance: Consumer Services
- HQL Investment Managers
- Sector
- QD Finance
- HQL Finance
- Exchange
- QD Nasdaq
- HQL Nasdaq
- Market Cap
- QD 433.7M
- HQL 391.1M
- IPO Year
- QD 2017
- HQL N/A
- Fundamental
- Price
- QD $2.46
- HQL $13.80
- Analyst Decision
- QD
- HQL
- Analyst Count
- QD 0
- HQL 0
- Target Price
- QD N/A
- HQL N/A
- AVG Volume (30 Days)
- QD 491.2K
- HQL 120.9K
- Earning Date
- QD 12-09-2024
- HQL 01-01-0001
- Dividend Yield
- QD N/A
- HQL 11.56%
- EPS Growth
- QD N/A
- HQL N/A
- EPS
- QD N/A
- HQL 0.79
- Revenue
- QD $27,875,484.00
- HQL N/A
- Revenue This Year
- QD N/A
- HQL N/A
- Revenue Next Year
- QD N/A
- HQL N/A
- P/E Ratio
- QD N/A
- HQL $17.08
- Revenue Growth
- QD N/A
- HQL N/A
- 52 Week Low
- QD $1.52
- HQL $11.34
- 52 Week High
- QD $2.60
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- QD 61.91
- HQL 33.42
- Support Level
- QD $2.27
- HQL $13.70
- Resistance Level
- QD $2.50
- HQL $14.37
- Average True Range (ATR)
- QD 0.09
- HQL 0.27
- MACD
- QD -0.00
- HQL -0.10
- Stochastic Oscillator
- QD 95.65
- HQL 7.10
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.